| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 19.991 | 39.336 | 44.272 | 43.334 | 42.281 |
| Total Income - EUR | - | - | - | - | - | 20.920 | 39.336 | 48.733 | 43.381 | 42.281 |
| Total Expenses - EUR | - | - | - | - | - | 20.048 | 37.619 | 47.113 | 31.606 | 35.584 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 872 | 1.717 | 1.621 | 11.775 | 6.697 |
| Net Profit/Loss - EUR | - | - | - | - | - | 266 | 537 | 378 | 9.888 | 5.620 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Endocarmar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 8.395 | 5.392 | 2.584 | 1.434 | 0 |
| Current Assets | - | - | - | - | - | 4.870 | 9.553 | 7.750 | 11.809 | 15.194 |
| Inventories | - | - | - | - | - | 3.310 | 3.237 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 113 | 222 | 8.006 | 4.154 |
| Cash | - | - | - | - | - | 1.560 | 6.203 | 7.528 | 3.803 | 11.041 |
| Shareholders Funds | - | - | - | - | - | 307 | 837 | 1.218 | 11.102 | 5.669 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 15.477 | 14.108 | 9.116 | 2.140 | 9.590 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Endocarmar S.r.l.